Gufic Biosciences informs about press release

05 Apr 2022 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gufic Biosciences has informed that it enclosed a press release being issued by the Company titled ‘Gufic receives DCGI nod for Thymosin Alpha – 1’.

The above information is a part of company’s filings submitted to BSE.

Gufic Biosciences Share Price

317.05 5.85 (1.88%)
22-Jan-2026 09:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1640.20
Dr. Reddys Lab 1211.15
Cipla 1377.95
Zydus Lifesciences 882.00
Lupin 2176.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×